Pneumococcal infection surveillance in Lebanon
Lebanese Interhospital Pneumococcal Surveillance Program (LIPSP)
This study is trying to find out which types of bacteria cause serious infections like pneumonia in Lebanon and how well current vaccines and antibiotics work against them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 700 (estimated) |
| Ages | 1 Day and up |
| Sex | All |
| Sponsor | American University of Beirut Medical Center Academic / other |
| Locations | 1 site (Beirut) |
| Trial ID | NCT00901602 on ClinicalTrials.gov |
What this trial studies
This observational program aims to identify the serotypes of Streptococcus pneumoniae responsible for invasive infections such as pneumonia, meningitis, and sepsis in Lebanon. By collecting bacterial isolates from patients across various hospitals, the study will analyze their antibiotic sensitivity and assess the effectiveness of existing pneumococcal vaccines. The findings will provide valuable insights for healthcare providers in Lebanon regarding the prevention and treatment of these serious infections.
Who should consider this trial
Good fit: Ideal candidates include patients of all ages with culture-proven invasive pneumococcal infections admitted to hospitals in Lebanon.
Not a fit: Patients with non-S. pneumoniae isolates will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of pneumococcal infections and improve vaccination strategies, ultimately reducing the incidence of severe disease.
How similar studies have performed: Similar studies have shown success in identifying serotypes and their antibiotic resistance patterns, making this approach well-established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Samples included in the study are those that are: * culture proven * invasive pneumococcal infections * in patients of all ages admitted to different hospitals all over Lebanon * Acceptable samples include: * positive isolates from blood * cerebrospinal fluid * other normally sterile body sites such as empyema fluid, abscesses, joint fluid, middle ear fluid obtained by tympanocentesis in the operating room, and lung needle aspiration Exclusion Criteria: * non S. pneumoniae isolates
Where this trial is running
Beirut
- American University of Beirut — Beirut, Lebanon (Recruiting)
Study contacts
- Principal investigator: Ghassan S Dbaibo, M.D. — American University of Beirut Medical Center
- Study coordinator: Ghassan S Dbaibo, M.D.
- Email: gdbaibo@aub.edu.lb
- Phone: +961-1-749235
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.